ENGAGE Multiple Myeloma
October 2021
The concept of shared decision making is revolutionizing the way patients engage with their healthcare team, improving outcomes by encouraging them to play a more active role in their care. The ENGAGE program provides tools and actions for shared decision making and tips for navigating multiple myeloma treatment decisions.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding Multiple Myeloma
Understanding Your Role in Myeloma Treatment Decisions
October 28, 2021
What You Should Know About Myeloma Clinical Trial Participation
October 28, 2021
What Key Steps Should Follow a Myeloma Diagnosis?
October 20, 2021
How Can Myeloma Caregivers Provide Support?
August 10, 2021
Who Is On Your Myeloma Healthcare Team?
August 10, 2021
How Does Myeloma Begin and Progress?
August 10, 2021
Are COVID-19 Vaccines Effective for Myeloma Patients?
August 10, 2021
How to Make an Informed Myeloma Treatment Decision
July 23, 2021
Is the COVID-19 Vaccine Safe for Myeloma Patients?
March 31, 2021
Myeloma Treatment Decisions: What Should Be Considered?
March 31, 2021
Multiple Myeloma Treatment
An Expert’s Hopeful Outlook on Myeloma Research and Treatment
October 28, 2021
An Expert Reflects on Hopeful Advances in Myeloma Treatment
October 20, 2021
Myeloma Research: What’s the Latest Treatment News?
August 10, 2021
How Will I Know If My Myeloma Treatment Is Working?
August 10, 2021
What Key Questions Should Myeloma Patients Ask About Treatment?
August 10, 2021
Myeloma Test Results and Factors That Impact Treatment Decisions
August 10, 2021
What Are the Goals of Myeloma Treatment?
August 10, 2021
An Expert’s Take on Promising Myeloma Treatment and Research
March 31, 2021
Which Myeloma Patients Should Consider Stem Cell Transplant?
March 31, 2021
ENGAGE Multiple Myeloma Resources
This program is supported by AbbVie, Bristol Myers Squibb, Karyopharm, and through generous donations from people like you.